Molecular and biochemical evidence on the protection of cardiomyocytes from phosphine-induced oxidative stress, mitochondrial dysfunction and apoptosis by acetyl-l-carnitine by Baghaei, A. et al.
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The  aim of  the  present  study  was  to investigate  the efﬁcacy  of  acetyl-l-carnitine  (ALCAR)  on pathologic
changes  of  mitochondrial  respiratory  chain  activity,  ATP  production,  oxidative  stress,  and  cellular  apo-
ptosis/necrosis  induced  by  aluminum  phosphide  (AlP)  poisoning.  The  study  groups  included:  the  Sham
that  received  almond  oil  only;  the  AlP  that  received  oral  LD50 dose  of  aluminum;  the  AC-100,  AC-200,  and
AC-300  which  received  concurrent  oral  LD50 dose  of  AlP  and  single  100,  200,  and  300 mg/kg  of  ALCAR  by
intraperitoneal  injection.  After 24  h, the rats  were  sacriﬁced;  the  heart  and  blood  sample  were  taken  foreywords:
cetyl-l-carnitine
ytochrome c oxidase
xidative stress
hosphine
measurement  of  biochemical  and  mitochondrial  factors.  The  results  speciﬁed  that  ALCAR  signiﬁcantly
attenuated  the  oxidative  stress  (elevated  ROS  and  plasma  iron  levels)  caused  by AlP  poisoning.  ALCAR
also increased  the  activity  of cytochrome  oxidase,  which  in  turn ampliﬁed  ATP  production.  Furthermore,
ﬂow  cytometric  assays  and caspase  activity  indicated  that ALCAR  prohibited  AlP-induced  apoptosis  in
cardiomyocytes.
© 2015  Elsevier  B.V.  All  rights  reserved.. Introduction
Pesticide poisoning is accountable for annually 300,000 casu-
lties around the world. Organophosphorus and metal phosphides
aluminum and zinc phosphide) keep the highest rate in this
egard. Aluminum phosphide (AlP) is widely used as an effective
nsecticide and rodenticide (in the shape of tablets, pellets, etc.) to
rotect stored grains (Mehrpour et al., 2012). Phosphine gas (PH3)
enerated from AlP combines with humidity in the air and plays
he pesticide role. PH3 is colorless and odorless (though impurities
n tablets cause garlic smell while sublimated). Moreover, phos-
hine density is approximately equal to the air (1.17 times) that
∗ Corresponding author.
E-mail address: Mohammad@TUMS.Ac.Ir (M.  Abdollahi).
ttp://dx.doi.org/10.1016/j.etap.2015.12.019
382-6689/© 2015 Elsevier B.V. All rights reserved.allows it to spread easily. PH3 is extremely toxic to aerobic and
metabolically active organisms (Nath et al., 2011). For instance,
ingestion of as small as 500 mg  of AlP would potentially result in
death for adults. The main clinically proven cause of death is severe
and refractory hypotension subsequent to heart failure (Siwach
et al., 1998). To date, there has been a little agreement on the
exact site or mechanism of action and it has yet to be determined.
Nevertheless, there are two  most accepted mechanisms for expla-
nation of PH3 toxicity; the ﬁrst is uncoupling of mitochondrial
electron transport chain through inhibition of mitochondrial
complex IV (cytochrome C oxidase) which leads to decreased ATP
production and cellular energy level. The second is induction of
oxidative stress via inhibition of antioxidant enzymes (superoxide
dismutase, catalase and peroxidase) and release of iron from trans-
ferrin that causes iron-catalyzed reactive oxygen species (ROS)
production by Fenton’s and Haber–Weiss reactions, resultant
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amage to cellular macromolecules and cell death (Anand et al.,
011). Despite numerous studies to ﬁnd an effective treatment
or AlP poisoning and proposing a variety of substances (including
rimetazidine, Mg-carrying nanoparticles, IMODTM, Vasopressin
lus milrinone, Iron sucrose, triiodothyronine, etc.) there is still no
ure for it (Abdolghaffari et al., 2015; Baeeri et al., 2013; Baghaei
t al., 2014; Duenas et al., 1999; Jafari et al., 2015; Solgi et al., 2015).
As mentioned above, probable mechanisms of PH3 toxicity are
uppression of mitochondrial respiration, inhibition of antioxi-
ant enzymes and enhancement of free iron-dependent reactive
xygen species (ROS) production. ALCAR is a natural occurring
ubstance which acts by stimulating energy metabolism. It is inti-
ately involved in transporting long-chain fatty acids across the
itochondrial inner membrane for oxidative phosphorylation and
TP production. Previous studies have indicated that ALCAR is capa-
le of increasing both activity and expression of mitochondrial
omplex IV in rat cardiomyocytes and mouse hepatocytes (Cha
nd Sachan, 1995; Cui et al., 2003). Furthermore, it is revealed
hat ALCAR modulates antioxidant enzymes in pathophysiologi-
al conditions (Loots et al., 2004). In addition, ALCAR has shown
emarkable ferrous metal ion chelating activity that is comparable
o EDTA (Gulcin, 2006). Moreover, it has been proven by several
n vitro studies that ALCAR is able to block mitochondrial pathway
poptosis, which plays a crucial role in cardiomyocytes death by AlP
ntoxication (Pillich et al., 2005). Based on given mechanisms, this
roject will focus on potential protective mechanisms of ALCAR in
cute AlP poisoning.
. Materials and methods
.1. Chemicals
AlP was purchased from Samiran Pesticide Formulating Co.
Tehran, Iran). ALCAR (99% purity) was purchased from Sigma
ldrich Chemie (Munich, Germany). The mitochondria isola-
ion kit was obtained from Bio-Chain Ins. (Newark, New Jersey,
SA). Annexin V-FITC/PI was obtained from Beijing Biosea
iotechnology Co, Ltd (Beijing, China). Adenosine diphosphate
ADP) sodium salt, adenosine triphosphate (ATP) disodium salt,
etrabutylammoniumhydroxide (TBAHS), methanol (HPLC grade),
olumn (SUPELCOSILTM LC-18-T) from Supelco (Antrim, UK),
cetic acid, FeCl3·6H2O, sodium sulfate, trichloroacetic acid (TCA),
otassium dihydrogen phosphate anhydrous (KH2PO4, analyti-
al grade), 2,4,6-tripyridyl-s-triazine (TPTZ), 2-thiobarbituric acid
TBA), rotenone, 2,6-dichloroindophenol (DCIP), antimycin A, colla-
enase and other chemicals were of the highest purity available and
ere purchased from Sigma Aldrich Chemie (Munich, Germany).
.2. Animals
Male Wistar rats weighing between 200 and 220 g were used
n the study. Animals were housed singly in standard cages in a
ontrolled room temperature and humidity and light–dark cycle.
nimals were fed a normal laboratory diet. Rats were deprived of
ood for 12 h prior to experiments, but were allowed free access to
ap water. Experiments followed a protocol that was approved by
he institutional review board and the ethics committee with code
umber 91-03-33-19006.
.3. Experimental design
Forty-ﬁve rats were randomly assigned to ﬁve groups of each
ine animals. AlP was dispersed in almond oil and administered
y gavage. ALCAR was  dissolved in sterile normal saline (NS)
nd administered intraperitoneally (IP) at doses of 100, 200 and
00 mg/kg. Doses of ALCAR were picked from previous studies (Jia and Pharmacology 42 (2016) 30–37 31
et al., 2014; Paradies et al., 1992; Patel et al., 2012). Pentobarbital
was used for induction of anesthesia.
Animals which received almond oil only was named as Sham;
aluminum phosphide as AlP; AlP + ALCAR (100 mg/kg) as AC-100;
AlP + ALCAR (200 mg/kg) as AC-200; AlP + ALCAR (300 mg/kg) as AC-
300.
Prior to the beginning of experiment, animals were fasted for
12 h. AlP was gavaged to all animals except for Sham group. All
treatments were performed after 30 min  to all groups except for
Sham and AlP group. At 24 h post treatments, the animals were
decapitated and the heart and blood were removed. Plasma was
separated from blood and frozen at −20 ◦C. The heart was rinsed
in ice-cold saline. Six heart samples of each group were frozen in
liquid nitrogen and stored at −80 ◦C for further mitochondrial and
biochemical studies and three samples were immediately used for
ﬂow cytometric analysis.
2.4. Determination of AlP LD50
Karber’s method was  used to determine the LD50 of obtained AlP
powder. According to the method, four groups of each containing
four rats were selected and AlP was  administered at doses of 8,
10, 12, and 14 mg/kg. The calculated LD50 based on the number of
dead animals after 24 h was  approximately 12 mg/kg (Baghaei et al.,
2014).
2.5. Mitochondrial isolation and assay for mitochondrial function
According to Sigma mitochondrial isolation kit instructions,
100 mg  (50–200 mg)  of fresh heart tissue, which was  collected 24 h
after treatment was used. Through the 15 steps of tissue treat-
ment (involving three-step centrifugation), tissue mitochondria
were isolated. Isolated mitochondrial samples were immediately
assayed for protein content and refrigerated for mitochondrial
complexes activity assays. All procedures were done under the
temperature 0–4 ◦C.
2.6. Measurement of complex I (NADH dehydrogenase) activity
The basis of this test is measuring the oxidation of NADH to
NAD at 340 nm with 380 nm as the reference wavelength at 37 ◦C.
The assay of complex I (NADH dehydrogenase) was performed
on 25 mM KPO4 buffer (pH 7.2) containing mitochondrial protein
(6 mg), 5 mM MgCl2, 1 mM KCN, 1 mg/ml  BSA, and 150 M NADH;
the reaction was  initiated by the addition of coenzyme Q (50 M).
In this reaction, ubiquinone is the ﬁnal electron acceptor. The dif-
ference in activity with and without rotenone at a fully saturating
level of 5 mM is calculated to differentiate complex I activity from
that of the rotenone-insensitive NADH, ubiquinone oxidoreductase
(Janssen et al., 2007).
2.7. Measurement of complex II (succinate dehydrogenase)
activity
The enzymatic activity of Complex II was  determined spec-
trophotometrically by the rate of succinate-driven, co-enzyme
Q2-related reduction of dichlorophenolindophenol (DCPIP). Brieﬂy,
mitochondria were incubated in phosphate buffer (pH 7.4) con-
taining 40 M DCPIP, 1 mM KCN, 10 M rotenone, and 50 M
co-enzyme Q2. The rate of DCPIP reduction to DCPIPH2 was  deter-
mined at 600 nM.  At the end of each run thenoyltriﬂuoroacetone
(1 mM)  was  added and the residual TTFA insensitive rate was sub-
tracted (Tompkins et al., 2006).
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.8. Measurement of complex IV (cytochrome-c oxidase) activity
Method of Smith was used to assay cytochrome oxidase kinet-
cs. Brieﬂy, the ferrocytochrome c oxidation rate was measured by
ubsequent declines in absorbance at 550 nm.  The assays were per-
ormed by using 50 mm PO4-2 (pH 7.0), 2% lauryl maltoside, and
 g of mitochondrial protein. For the initiation of the reaction,
errocytochrome c was added at a concentration of 40 mm.  Speciﬁc
ctivity was determined from mean values of three to four mea-
urements using 21.1 mM−1 cm−1 as the extinction coefﬁcient of
errocytochrome c at 550 nm (Smith, 1955).
.9. Measurement of cardiac ADP and ATP
Isolated hearts were minced and homogenized in 1 ml  of 6% ice-
old TCA. The homogenate was centrifuged at 12,000 × g for 10 min
t 4 ◦C. The supernatant was neutralized by 4 M KOH to pH 6.5,
ltered through a Millipore ﬁlter (pore size 0.45 m),  and used to
etermine the quantity of ATP and ADP (g/ml per mg  of tissue)
sing Ion-pair HPLC (Baeeri et al., 2013).
.10. Measurement of free plasma iron
Performed by the spectrophotometric method of Nilsson et al.
rieﬂy 2 ml  of ventricular blood was taken after the decapitation
f each animal, transferred into heparinated tubes and centrifuged
t 1000 × g for 10 min  to separate plasma from cells. Plasma sam-
les, then ﬁltered through Millipore ﬁlters. Two 75 l portions of
ltered plasma were drawn and BPS was added to one of them.
fter 15 min, the absorption was seen at 535 nm and free plasma
ron concentration was calculated from the difference of absorption
Nilsson et al., 2002).
.11. Measurement of ROS
ROS generation in heart tissue was measured by dichloroﬂuo-
escein (DCF) probe using LeBel and Bondy method. The DCF assay
as performed within 1 h of tissue sampling. Brieﬂy, fresh 2′,7′-
ichloroﬂuorescin acetate (DCFH-DA) stock solution was  made by
issolving it in 1.25 mM methanol and kept in a dark room at 0 ◦C.
0 l of homogenate were added to a cuvette containing 3 l of
.1 M phosphate buffer (pH 7.4), and 12 l of 1.25 mM DCFH-DA
total volume 5 0.3 ml). DCFH-DA was dissolved in methanol to
acilitate the penetration into cells. The mixture was  incubated for
5 min  at 37 ◦C to allow the DCFH-DA probe to cross any mem-
ranes and for nonspeciﬁc esterases to cleave to diacetate groups.
CF formation was determined by a spectroﬂuorometer at excita-
ion wavelength of 488 nm and emission wavelength of 525 nm at
7 ◦C. Measurements were made every 15 min  for 60 min, and lin-
ar DCF production rate was determined relative to the amount of
rotein added to the cuvette. The results are showed as nanomole
CF formed per minute per milligram protein (Brubacher and Bols,
001).
.12. Measurement of superoxide dismutase (SOD) activity
The activity of SOD was determined according to the method
f Minami and Yoshikawa. In brief, tissue homogenates were put
or 2 min  in 0.154 M NaCl solution (1:50, W/V) at 4 ◦C. Then 5 ml  of
ixture was shaken with ethanol and chloroform and centrifuged
or 60 min  at 15,000 × g. The supernatant was used as the stopper
f pyrogallol auto-oxidation reaction and the difference between
uto-oxidation of pyrogallol alone and in the presence of cytosolic
raction determined enzymatic activity (Minami and Yoshikawa,
979). and Pharmacology 42 (2016) 30–37
2.13. Measurement of catalase (CAT) activity
For determination of tissue catalase activity, method of Slaugh-
ter and O’brien was used. The basis of this method is a colorimetric
reaction in which the reaction between color producing reagent
(reagent 1) and reaction-initiating reagent (reagent 2) produces
hydrogen peroxide that in reaction with Trinder reagent (AP and
DHBS) by the enzyme horse radish peroxidase generates a color
with 505 nm absorbance. Presence of tissue catalase, inhibits the
color development. One unit of catalase activity was deﬁned as
the amount of enzyme activity that causes 50% inhibition of color
development (Slaughter and O’Brien, 2000).
2.14. Measurement of cellular apoptosis by active caspase-3
The test was carried out by using “Sigma Caspase 3 Assay Kit”.
The Caspase 3 Colorimetric Assay Kit is based on the hydrolysis
of acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA) by cas-
pase 3, resulting in the release of the p-nitroaniline (pNA) moiety.
The pNA is detected at 405 nm (mM = 10.5). The concentration of
the pNA released from the substrate is calculated from either the
absorbance values at 405 nm.
2.15. Measurement of cellular apoptosis by active caspase-9
“Abcam Caspase-9 Colorimetric Assay Kit” was used to deter-
mine the amount of active caspase-9. Activation of ICE-family
proteases/caspases initiates apoptosis in mammalian cells. The
assay is based on spectrophotometric detection of the chro-
mophore p-nitroaniline (pNA) after cleavage from the labeled
substrate LEHD-pNA. The PNA light emission can be quantiﬁed
using a Microtiter plate reader at 405 nm.
2.16. Determination of cell viability by ﬂow cytometry
As mentioned above, three heart samples of each group were
used for the ﬂow cytometric assay. Left ventricles were rapidly
removed and underwent cardiomyocyte isolation by collagenase
digestion according to Schluter and Schreiber method (Schluter
and Schreiber, 2005). Afterward, the cells were washed with
phosphate-buffered saline (PBS) at room temperature and stained
with annexin V-FITC and propidium iodide (PI). The stained cells
were incubated in binding buffer and analyzed cell death by ﬂow
cytometry (Apogee, UK). Data were provided and analyzed with
the apogee histogram software. Density plots of ﬂow cytometry
are included; the percentage of viable cells (lower left quadrant;
annexin V−; PI−), the percentage of apoptotic cells (lower right
quadrant; annexin V+; PI−), late apoptotic cells (upper right quad-
rant; annexin V+; PI+), and necrotized cells (upper left quadrant;
annexin V−; PI+) (Jafari et al., 2015).
2.17. Statistical analysis
The StatsDirect version 3.0.150 was used for the analyses. Data
are expressed as mean ± standard error of the mean (SEM). One-
way analysis of variance (ANOVA) followed by Tukey’s post hoc
for multiple comparisons was used. P values less than 0.05 were
considered statistically signiﬁcant.
3. Results
3.1. Activity of mitochondrial complexesNo signiﬁcant change in complex I activity was observed
between groups (P > 0.05). As well, levels of succinate dehydro-
genase activity were comparable between all groups and neither
A. Baghaei et al. / Environmental Toxicology and Pharmacology 42 (2016) 30–37 33
Fig. 1. Activity of mitochondrial complexes after treatments. Values are mean ± SEM. aP < 0.05 vs the Sham group; bP < 0.05 vs the AlP group. Sham: no interventions; AlP:
aluminum phosphide at dose of LD50; AC-100: acetyl-l-carnitine at dose of 100 mg/kg; AC-200: acetyl-l-carnitine at dose of 200 mg/kg; AC-300: acetyl-l-carnitine at dose
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xposure to AlP nor the administration of ALCAR changed the activ-
ty of mitochondrial complex II as compared to the Sham group
P > 0.05). Whereas, AlP led to a signiﬁcant decrease in cytochrome-
 oxidase activity when compared to Sham (P < 0.05) while the
dministration of ALCAR at all doses caused signiﬁcant rise in com-
lex IV activity (P < 0.05) and activity levels in all three groups were
ear to that of the Sham group (P < 0.05, Fig. 1).
.2. Cardiac ADP/ATP ratio
The ADP/ATP ratio was higher in the AlP group compared to the
ham (P = 0. 000). The ADP/ATP ratio in all ALCAR-treated groups
as lower than that of the AlPs (P < 0.01). Whereas, a higher ADP
o ATP ratio was observed in ALCAR treated groups as compared to
he Sham (P < 0.05, Fig. 2).
ig. 2. ADP/ATP ratio in heart tissue. Values are mean ± SEM. aP < 0.05 vs the Sham group
ose  of LD50; AC-100: acetyl-l-carnitine at dose of 100 mg/kg; AC-200: acetyl-l-carnitine3.3. Reactive oxygen species (ROS)
The ROS value was  signiﬁcantly higher in the AlP group com-
pared to the Sham (P < 0.01). Treatment by ALCAR led to remarkable
decline in ROS as compared to Sham (P < 0.05). Though ROS lev-
els were signiﬁcantly higher than the Sham in all ALCAR treated
groups (P < 0.05). Among ALCAR groups, AC-300 showed lower, but
non-signiﬁcant ROS value (P > 0.05, Table 1).
3.4. Free plasma ironAcute oral exposure to AlP leaded to signiﬁcant rise in plasma
iron as compared to the Sham group (P < 0.001). Administration of
ALCAR at all doses caused a remarkable decline in free plasma iron
in comparison with the AlP group (P < 0.001). Moreover, plasma iron
; bP < 0.05 vs the AlP group. Sham: no interventions; AlP: aluminum phosphide at
 at dose of 200 mg/kg; AC-300: acetyl-l-carnitine at dose of 300 mg/kg.
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Table 1
Levels of different biochemical parameters after treatment.
Groups ROS* (U/mg protein) Free plasma iron (M) CAT# activity (U/mg protein) SOD+ activity (U/mg protein)
Sham 18.39 ± 4.45 1.58 ± 0.15 28.11 ± 3.12 0.31 ± 0.03
AlP  88.25 ± 3.65a 6.43 ± 0.37a 17.14 ± 1.09a 0.39 ± 0.13
AC-100  46.54 ± 6.30a,b 2.76 ± 0.17a,b 31.99 ± 3.04a,b 0.40 ± 0.08
AC-200  55.59 ± 5.99a,b 2.50 ± 0.13a,b 25.86 ± 4.60b 0.38 ± 0.07
AC-300  45.36 ± 8.26a,b 2.82 ± 0.19a,b 29.09 ± 5.63b 0.36 ± 0.01
Values are mean ± SEM. Sham: no interventions; AlP: aluminum phosphide at dose of LD50; AC-100: acetyl-l-carnitine at dose of 100 mg/kg; AC-200: acetyl-l-carnitine at
dose  of 200 mg/kg; AC-300: acetyl-l-carnitine at dose of 300 mg/kg.
a P < 0.05 vs the Sham group.
b P < 0.05 vs the AlP group.
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c* ROS: reactive oxygen species.
# CAT: catalase.
+ SOD: superoxide dismutase.
evels in all ALCAR groups were comparable to the Sham (P > 0.05,
able 1).
.5. Antioxidant enzymes
No signiﬁcant changes were observed between groups in the
ase of SOD activity (P > 0.05). A signiﬁcant lower CAT level was
een in the AlP group as compared to the Sham (P < 0.05). The level
f CAT in AC-100 and AC-300 groups was near to that of the Sham
nd both were signiﬁcantly higher than the AlP (P < 0.05). CAT level
ig. 3. Flow cytometry assay of apoptosis and necrosis. Each square presents the percen
nnexin V+/PI−: early apoptotic cells (the number in right lower quadrant); annexin V+/P
ells  (the number in left upper quadrant). Plots are representative of the results in ﬁve diin AC-200 group showed no statistical difference compared to the
Sham and the AlP groups (P > 0.05, Table 1).
3.6. Cell viability
A signiﬁcant difference in viable cells was  seen among AlP and
Sham group (P = 0.001). Cell viability was  signiﬁcantly raised in all
ALCAR groups when compared to AlP (P < 0.05). Cell viability in AC-
100 and AC-300 was  near to that of the Sham group (P > 0.05).
Fraction of early and late apoptotic cells was  also signiﬁcantly
tage of cells for annexin V−/PI−: viable cells (the number in left lower quadrant);
I+: late apoptotic cells (the number in right upper quadrant); and V−/PI+: necrotic
fferent experiments.
A. Baghaei et al. / Environmental Toxicology and Pharmacology 42 (2016) 30–37 35
Fig. 4. Percentage of viable/apoptotic/necrotic cells from the ﬂow cytometry assay. Values are mean ± SEM. aP < 0.05 vs the Sham group; bP < 0.05 vs the AlP group. Sham:
no  interventions; AlP: aluminum phosphide at dose of LD50; AC-100: acetyl-l-carnitine at dose of 100 mg/kg; AC-200: acetyl-l-carnitine at dose of 200 mg/kg; AC-300:
acetyl-l-carnitine at dose of 300 mg/kg.
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cig. 5. Effect of treatments on activation of caspases. Values are mean ± SEM. aP < 0.
hosphide at dose of LD50; AC-100: acetyl-l-carnitine at dose of 100 mg/kg; AC-200:
aised as compared to that of Sham (P < 0.01). Necrotic population
ere comparable between Sham, AlP, and AC-300 (P > 0.05), while
C-100 and AC-200 showed signiﬁcant elevated values as com-
ared to Sham and AlP (P < 0.05). All ALCAR groups showed notable
ecrease in early apoptosis compared to AlP (P < 0.005). However,
C-100 and AC-200 showed higher necrotic cells as compared to
oth Sham and AlP (P < 0.05, Figs. 3 and 4).
.7. Caspase-3 and caspase-9 activities
Signiﬁcantly higher caspase-3 and caspase-9 levels were
bserved in the AlP group compared to the Sham (P < 0.01). All
LCAR groups showed signiﬁcant lower values as compared to the
lP group (P < 0.05); however, notable increase was  observed in
ll groups in comparison with the Sham (P < 0.05). AC-200 showed
he lowest caspase-3 level between ALCAR treated groups, but the
ifference was not statistically signiﬁcant (P > 0.05), whilst in the
ase of caspase-9, AC-300 showed lower but non-signiﬁcant value
P > 0.05). Late apoptotic population in AC-300 group was  signiﬁ-
antly lower than the AlP group (P < 0.05), while the other ALCARhe Sham group; bP < 0.05 vs the AlP group. Sham: no interventions; AlP: aluminum
l-l-carnitine at dose of 200 mg/kg; AC-300: acetyl-l-carnitine at dose of 300 mg/kg.
groups showed comparable results as compared to AlP (P > 0.05).
The AlP group did not show a signiﬁcant difference from Sham in
the percent of necrotic cells (P < 0.05, Fig. 5).
4. Discussion
Returning to the results, it is now possible to state that ALCAR is
able to overwhelm the diverse toxic mechanisms of AlP. Mortality
rate of about 70% makes AlP of most hazardous pesticides. Car-
diac toxicity is the major sign of AlP toxicity plus severe ventricular
arrhythmias and refractory hypotension as main clinical causes of
death (Bogle et al., 2006).
Cardiomyocytes are contractile cells that form 75% of heart
tissue and are responsible for its vital role in blood circulation
(Brilla et al., 1991). Mitochondria play a central role in the function
of cardiomyocytes. They constitute about 30% of the total car-
diomyocytes volume and provide 90% of cellular energy (Carvajal
and Moreno-Sanchez, 2003). Electron transport chain (ETC) which
is located in the inner membrane of mitochondria is the gener-
ator of ATP for cardiomyocytes contractile function. Inhibition
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f mitochondrial respiration via blockage of ETC leads to ATP
epletion (King and Bailey, 2010). Phosphine is strong inhibitor of
TC. In vitro studies demonstrated that mitochondrial complex IV
cytochrome-c oxidase) is the main target of phosphine (Nath et al.,
011). The inhibition occurs through reduction of Fe3+ in the heme
tructure of cytochrome-a, diminishing the electron-accepting
roperty, and the consequent interruption of ATP production. Stud-
es report a 45% decrease in mitochondrial complex IV, whereas
here are controversial reports from no inhibition to 49% inhibition
bout complexes I and II (Dua and Gill, 2004; Singh et al., 2006).
everal reports have shown the ability of ALCAR to increase the
ctivity and expression of complex IV in cardiomyocytes and hep-
tocytes of rat (Mawal et al., 1998; Paradies et al., 1992). According
o the results of our study, phosphine caused near 50% decline in
omplex IV activity while no inhibition was observed in complex
 and II. One interesting ﬁnding is return of complex IV activity to
he normal state by administration of ALCAR. These ﬁndings are
onsistent with prior studies (Singh et al., 2006). Moreover, inhibi-
ion of ETC by phosphine turned the normal cellular ADP/ATP ratio
f 0.35–1.46 that indicates the depletion of ATP pool. As expected,
LCAR at all doses was capable of restoring cellular ATP content.
One consequence of ETC inhibition is oxidative stress caused by
eneration of ROS from the transport of ETC electrons to molecu-
ar oxygen and the formation of superoxide anion (O2−) (Mehrpour
t al., 2014). In normal condition, this radical has a short life and
itochondrial superoxide dismutase (SOD) rapidly converts it to
ydrogen peroxide (H2O2). Hydrogen peroxide is also eliminated by
atalase (CAT) and glutathione peroxidase (GPx). Otherwise, it can
ttack cellular macromolecules and lead to cell death. Phosphine
oisoning can lead to excessive ROS generation through two paral-
el mechanisms. The ﬁrst is overproduction of ROS by disruption of
he electron pathway in ETC. The latter mechanism is the alteration
f antioxidant enzyme activity. Several studies have linked phos-
hine toxicity to increase in SOD instead of decreasing CAT and GPx
ctivity. As pointed out in several studies, ALCAR could reduce SOD
ctivity (reduction in O2−) and simultaneously increase the activity
f CAT (increasing elimination of H2O2) (Gulcin, 2006; Loots et al.,
004).
The other mechanism considered to play a part in phosphine-
nduced oxidative stress is rise of free plasma iron (Cha’on et al.,
007). Due to extreme toxicity, cellular free iron level is always
ontrolled and maintained about 10−18 M for Fe3+ and 10−8 M for
e2+. Ferritin, a protein complex composed of 24 subunits, keeps the
alance between soluble and insoluble ferrihydrite iron (Harrison
nd Arosio, 1996). It has been proved that insoluble Fe3+ can be
educed and released from ferritin by the act of strong reducing
gents (PH3, for instance). The soluble Fe2+ can generate ROS via
enton and Haber–Weiss reactions (Cha’on et al., 2007). Gulcin has
hown that ALCAR, owing to its hydroxyl and carboxyl groups, can
cavenge Fe2+ and hinder the ROS forming reactions (Gulcin, 2006).
n this study, ALCAR successfully diminished elevated level of AlP
nduced ROS by three following actions: increasing the activity (and
xpression, probably) of cytochrome-c oxidase, enhancement of
AT activity, and at last, reduction in free plasma iron by its che-
ating property.
There are clear evidences that overproduction of ROS can lead
o apoptosis acting as a second messenger. Studies have shown
hat ROS induced apoptosis can be mediated by both extrinsic
nd intrinsic pathways. In the extrinsic pathway, ROS act as death
eceptor activator. While in the intrinsic (mitochondrial) path-
ay, ROS induced mitochondrial DNA damage stimulates outer
embrane permeabilization and translocation of cytochrome c to
ytosol, activation of initiator caspase-9 that cleaves and activates
ffector caspases 3 and 7 (Solgi et al., 2015). Hence, to conﬁrm the
ccurrence of apoptosis, we investigated active caspase-3 and to
etermine the contribution of intrinsic pathway, we examined the and Pharmacology 42 (2016) 30–37
active caspase-9. ALCAR has been found to prevent apoptosis in
several studies. Pillich et al. demonstrated the ability of ALCAR to
prevent cytochrome c induced apoptosis along with stimulation of
cell proliferation in cultured mouse ﬁbroblasts (Pillich et al., 2005).
Further studies on yeast and DT40 cells showed similar beneﬁcial
effects (Palermo et al., 2010; Zhu et al., 2008).
The results of ﬂow cytometry assay show signiﬁcant rise in early
and late apoptotic cell population in AlP treated rats. On the other
hand, concurrent ALCAR treatment prohibited phosphine induced
apoptosis. One unanticipated ﬁnding was  that in AC-100 and AC-
200 the necrotic fractions were signiﬁcantly raised compared to
AlP. It is considered that the inhibition of AlP induced apoptosis by
ALCAR along with elevated cellular ROS led to massive damage to
cellular structures and necrosis.
The results of caspase-3 and caspase-9 assays seem to be con-
sistent with other research which found ROS induced apoptosis
is primarily conducted through the mitochondrial pathway (Jafari
et al., 2015; Solgi et al., 2015). However, according to the extent
of rise in active caspases against the control, it is concluded that
extrinsic pathway participates in ROS induced apoptosis as well.
5. Conclusion
As a ﬁnal point, it has been concluded that ALCAR has promising
therapeutic effects of AlP poisoning by suppressing the pathways
leading to oxidative stress and cell injury. From the hopeful results
of this study, in addition to a long history of safety with the ALCAR,
it would be interesting to assess the potential therapeutic role of it
in the clinical settings of AlP poisoning.
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